Recommended

New webinar: The path to optimisation in pharmaceutical microbiology
New webinar in 2025: Trends for life sciences quality leaders in 2025 – mastering what matters! Register your details now to secure your place!
New upcoming webinar: Navigating pharmaceutical environmental monitoring in a changing industry! Register your details today!
Explore our new Pharma Horizons: Sustainability report for key developments in the pharmaceutical industry!
Discover more in our new application note: validating recombinant cascade reagents in 3 simple steps
whitepaper

Whitepaper: PAT leads the way in the adoption of continuous manufacturing processes

Martin Gadsby, CEO & Director at Optimal Industrial Technologies and Flavio Belvedere, Co-Founder of ABCS Srl, look at the benefits of PAT and the aspects to consider when deploying it.

The use of data to gain actionable insight into manufacturing and processing activities, to optimise them and attain continuous flows, is at the heart of the fourth industrial revolution. In the chemical and biotechnology sectors, where complex chemical reactions and bioprocesses may be required to deliver key products, it is essential to have an in-depth, data-driven understanding of how critical process parameters (CPPs) influence a product’s critical quality attributes (CQAs). To achieve this, businesses should implement process analytical technology (PAT) strategies. In this way, they can manage the complexity of, and effectively control, their processes. This article describes the benefits of this approach and what should be considered when deploying PAT for continuous processing and manufacturing.